Our new paper has just been posted in the journal Global Advances in Health and Medicine.
In this paper we present the edited testimonials of caregivers of subjects who received sulforaphane as part of the original study (published in 2014). Sixteen caregivers of subjects originally given sulforaphane responded to requests for further information. Six of the 16 subjects did not continue taking a supplement after their participation in the original study ended. Years after the study ended, 9 of them are still taking a dietary supplement that delivers sulforaphane.
Latest posts by Cullman Chemoprotection Center (see all)
- Exciting Recent Paper on Inflammation and Nrf2 - July 16, 2018
- Sulforaphane and Epilepsy - July 11, 2018
- New Study from Korea: Sulforaphane Has Positive Effects in a Mouse Model of Alzheimer’s Disease - July 5, 2018